Riffyn and Imperial College Partner to Build Digital Foundations to Accelerate Synthetic Biology Research
An open-science collaboration between Riffyn, Imperial College’s Centre for Synthetic Biology (IC-CSynB), and SynbiCITE’s London Biofoundry sets the standard for a digital backbone for synthetic biology research and education in scientific reproducibility. Read more about how this collaboration was born in our blog post.
Tim Gardner is the Founder and the CEO of Riffyn. He was previously Vice President of Research & Development at Amyris, where he led the engineering of yeast strain and processes technology for large-scale bio-manufacturing of renewable chemicals. Tim has been recognized for his pioneering work in Synthetic Biology by Scientific American, the New Scientist, Nature, Technology Review, and the New York Times. He also served as an advisor to the European Union Scientific Committees and the Boston University Engineering Alumni Advisory Board. Tim enjoys hockey, running, mountain biking, and being beaten by his sons in almost everything.